Related Experiment Video
Updated: Jun 18, 2026
08:50
Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice
Published on: October 18, 2024
Duodenal bypass does not decrease glucose levels of lean individuals with gastric cancer submitted to partial or
Fernando A Herbella1, Ana C Tineli, Jorge L Wilson
1Department of Surgery, Division of Esophagus and Stomach, Universidade Federal de São Paulo, São Paulo, SP, Brazil. herbella.dcir@unifesp.epm.br
Arquivos De Gastroenterologia
|November 18, 2009
Summary
Duodenal bypass surgery after gastric cancer treatment did not significantly alter glucose levels in lean patients. This procedure, even with Roux-en-Y reconstruction, did not improve glycemic control in this specific population.
Area of Science:
- Metabolic surgery
- Gastroenterology
- Oncology
Background:
- Bariatric operations involving duodenal bypass are known to alter glucose metabolism.
- Gastric cancer surgery often requires extensive resection and reconstruction, potentially affecting metabolic pathways.
Purpose of the Study:
- To investigate the impact of duodenal bypass on glucose levels in lean individuals undergoing gastrectomy for gastric cancer.
- To assess whether Roux-en-Y reconstruction influences glycemic control post-gastrectomy.
Main Methods:
- Retrospective review of 56 non-diabetic and 6 diabetic patients.
- Patients underwent gastrectomy with Roux-en-Y reconstruction for gastric cancer.
- Analysis of glucose levels before and after surgical intervention.
Main Results:
- Post-operative glucose levels showed no significant alteration (P = 0.5).
- One diabetic patient on oral medication experienced improved diabetes control.
- Lean individuals did not exhibit decreased glucose levels following the procedure.
Conclusions:
- Duodenal bypass, as part of Roux-en-Y reconstruction for gastric cancer, does not appear to decrease glucose levels in lean patients.
- The metabolic effects of duodenal bypass may be context-dependent, not consistently observed in this cohort.
